Fig 1.
Geographic coverage of data datasets.
Reprinted from brightcarbon.com under a CC BY license, with permission from Bright Carbon, original copyright (2021). Each color represents the number of data partners with a presence in each state but does not necessarily correspond to the number of people. The darkest color represents those where all six partners had a presence.
Fig 2.
Study design diagram.
Fig 3.
Factors potentially associated with serological testing.
Pepe, 2001 Sep;2(3):249–60.
Table 1.
Clinical and demographic characteristics of patients with positive RNA and who underwent serological tests.
Table 2.
Positive percent agreement (PPA) 14–90 days after positive RNA test.
Table 3.
Positive percent agreement (PPA) by serology tests and presence of symptoms.
Fig 4.
Odds of seropositivity dataset A.
Fig 5.
Odds of seropositivity dataset B.
Fig 6.
Odds of seropositivity dataset C.
Fig 7.
Odds of seropositivity dataset D.
Fig 8.
Odds of seropositivity dataset E.
Fig 9.
Odds of seropositivity dataset F.